Professional Documents
Culture Documents
Anti-MUM1 Antibody Ab104803: 1 Abreviews 2 Images
Anti-MUM1 Antibody Ab104803: 1 Abreviews 2 Images
Anti-MUM1 Antibody Ab104803: 1 Abreviews 2 Images
2 Images
Overview
Product name
Anti-MUM1 antibody
Description
Tested applications
Species reactivity
Immunogen
Synthetic peptide corresponding to a region within N terminal amino acids 1-50 (MNLEGGGRGG EFGMSAVSCG
NGKLRQWLID QIDSGKYPGL VWENEEKSIF) of Human MUM1 (NP_002451).
Run BLAST with
Positive control
Purchase matching WB positive control:
Human MUM1 full length protein
Jurkat cell lysate; Human skin tissue
Properties
Form
Liquid
Storage instructions
Shipped at 4C. Upon delivery aliquot and store at -20C. Avoid freeze / thaw cycles.
Storage buffer
Preservative: None
Constituents: 2% Sucrose, PBS
Purity
Clonality
Polyclonal
Isotype
IgG
Applications
Our Abpromise guarantee covers the use of ab104803 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application
Abreviews
WB
Notes
Use a concentration of 0.5 g/ml. Predicted molecular weight: 52 kDa. Good results were obtained when
blocked with 5% non-fat dry milk in 0.05% PBS-T.
IHC-P
Use a concentration of 4 - 8 g/ml. Perform heat mediated antigen retrieval with citrate buffer pH 6 before
commencing with IHC staining protocol.
IHC-Fr
1/100.
Target
Function
Transcriptional activator. Binds to the interferon-stimulated response element (ISRE) of the MHC class I promoter.
Binds the immunoglobulin lambda light chain enhancer, together with PU.1. Probably plays a role in ISREtargeted signal transduction mechanisms specific to lymphoid cells.
Tissue specificity
Lymphoid cells.
Involvement in disease
Defects in IRF4 are a cause of multiple myeloma (MM) [MIM:254500]. MM is a malignant tumor of plasma cells
usually arising in the bone marrow and characterized by diffuse involvement of the skeletal system,
hyperglobulinemia, Bence-Jones proteinuria and anemia. Complications of multiple myeloma are bone pain,
hypercalcemia, renal failure and spinal cord compression. The aberrant antibodies that are produced lead to
impaired humoral immunity and patients have a high prevalence of infection. Amyloidosis may develop in some
patients. Multiple myeloma is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown
significance (MGUS) to plasma cell leukemia. Note=A chromosomal aberration involving IRF4 is found in multiple
http://www.abcam.com/MUM1-antibody-ab104803.html
Product Datasheet
myeloma. Translocation t(6;14)(p25;q32) with the IgH locus.
Sequence similarities
Cellular localization
Nucleus.
Please note: All products are "FOR RESEARCH USE ONLYAND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
http://www.abcam.com/MUM1-antibody-ab104803.html
Product Datasheet
**Regional variations to our Abpromise may apply to the following countries: China, Korea, Singapore, Malaysia, Taiwan and Thailand, which operate a 120 day guarantee.
Please contact your regional office for further details
http://www.abcam.com/MUM1-antibody-ab104803.html